Leica Biosystems, a global leader in automation and workflow solutions for anatomic pathology, announced the launch of Aperio PeerReview, a complete digital pathology software solution for toxicological pathologists conducting peer review studies in pre-clinical trials.

With barcode-driven automated integration of LIMS data and images, combined with customised viewing functionality, specific for toxicological pathology, Aperio PeerReview helps to reduce costs and improve efficiency in pre-clinical testing. Remote access to peer review slides and simultaneous, real-time discussion of non-concordant samples means that pathologists can conduct peer review studies without shipping slides or travelling.

"Aperio PeerReview is a significant breakthrough for pharmaceutical companies and CROs. It has been designed and developed in close collaboration with world-leading toxicological pathologists," said Anne Brumme, VP of ePathology at Leica Biosystems. "This launch further expands our range of solutions and demonstrates our commitment to satisfy the needs of the life science market."

Erio Barale-Thomas, principal scientist at Johnson & Johnson R&D will be presenting a complimentary webinar, "Peer Review through Digital Pathology: The Future is now?" September 30, 2014, focussing on the usage of Aperio PeerReview in toxicologic pathology.